Cyclops Medtech: A Diagnostic Platform for Neuro-Vestibular Disorders

Cyclops Medtech: A Diagnostic Platform for Neuro-Vestibular Disorders – Neuro-vestibular disorders are conditions that affect the balance and coordination of the body, such as vertigo, dizziness, migraine, epilepsy, concussion, and ADHD. These disorders can have various causes, such as inner ear problems, brain lesions, infections, trauma, or medications. They can also have serious consequences, such as falls, injuries, disability, and reduced quality of life. However, diagnosing and treating these disorders can be challenging, as they require specialized equipment, expertise, and protocols. This is where Cyclops Medtech, a diagnostic platform based in Bangalore, India, comes in.

cyclops medtech

Details of the startup:

  • CITY: Bengaluru
  • STATE: Karnataka
  • STARTED IN: 2015
  • FOUNDERS:  Niranjan Mysore Subbarao, Ravi Nayar and Srinivas Dorasala

You can find their website here.

OmiX Labs: Making Healthcare Accessible Through DNA Diagnostics

What is Cyclops Medtech?

Cyclops Medtech is a startup that was founded in 2015 by Dr. Srinivas Dorasala, Niranjan Subbarao, and Ravi Nayar, who are experts in the fields of ENT, engineering, and business. The startup is developing clinical and wearable diagnostic and rehabilitation products for neuro-vestibular disorders using eye-tracking technology. The startup’s flagship product is BalanceEye, a wearable device that can perform various tests to assess the vestibular function and diagnose the cause of dizziness and imbalance. The device uses a pair of eye-tracking goggles and a software module powered by algorithms to measure and analyze the eye movements of the patient during different stimuli and maneuvers. The device can also provide vestibular rehabilitation therapy using virtual reality and gamification.

MedGenome: A Global Leader in Genomics Research and Diagnostics

Why is Cyclops Medtech’s technology important?

Cyclops Medtech’s technology is important because it can provide a fast, accurate, and affordable solution for the diagnosis and management of neuro-vestibular disorders. According to the startup, more than 300 million people suffer from vertigo and dizziness worldwide, and more than 40% of them are misdiagnosed or underdiagnosed. The current methods of diagnosis, such as videonystagmography (VNG), caloric testing, and rotary chair testing, are expensive, cumbersome, and time-consuming. They also require dedicated infrastructure, trained personnel, and standardized protocols. Moreover, they are not widely available, especially in remote and rural areas.

Cyclops Medtech’s technology can overcome these limitations by using a portable, wearable, and user-friendly device that can perform various tests in a single session, without the need for any external equipment or stimuli. The device can also provide real-time and objective data, which can help the clinician to make a differential diagnosis and prescribe the appropriate treatment. The device can also be used for vestibular rehabilitation, which is a form of physical therapy that can help the patient to recover from the symptoms and improve their balance and coordination. The device can also be used for screening and monitoring of various conditions, such as concussion, epilepsy, and ADHD, which can affect the vestibular system and cause cognitive and behavioral impairments.

Cyclops Medtech

SigTuple: Revolutionizing Pathology and Diagnostics with AI

What are the achievements and future plans of Cyclops Medtech?

Cyclops Medtech has achieved several milestones and accolades since its inception. Some of the achievements are:

  • Funding: Cyclops Medtech has raised $3.5 million in its pre-Series A funding round, led by Unitus Ventures, along with participation from Axilor Ventures, Speciale Invest, and other angel investors. The startup has also received grants from the Biotechnology Industry Research Assistance Council (BIRAC) and the Department of Science and Technology (DST).
  • Recognition: Cyclops Medtech has been recognized as one of the top 10 startups in India by the Economic Times Startup Awards 2019. The startup has also been featured in various media outlets, such as Forbes, The Hindu, and YourStory.
  • Collaboration: Cyclops Medtech has collaborated with various institutions and organizations, such as the All India Institute of Medical Sciences (AIIMS), the National Institute of Mental Health and Neurosciences (NIMHANS), and the Indian Space Research Organisation (ISRO), to validate and deploy its technology for various applications.
  • Impact: Cyclops Medtech has installed more than 600 devices in over 200 clinics and hospitals across 12 countries, and has performed more than 1 million tests. The startup has also helped in the diagnosis and treatment of more than 300,000 patients suffering from neuro-vestibular disorders.

Cyclops Medtech plans to expand its product portfolio and launch new products for various neuro-vestibular disorders, such as migraine, epilepsy, concussion, and ADHD. The startup also plans to scale up its operations and reach out to more customers and partners across India and abroad.

Cyclops Medtech is a diagnostic platform that is providing early-stage diagnostic insights into various neuro-vestibular disorders using eye-tracking technology. The startup is creating a positive impact on the health and well-being of millions of people who suffer from dizziness, imbalance, and cognitive impairments. Cyclops Medtech is a shining example of how deep tech can solve real-world problems and create social good.

Ellume Health: The Next Generation of Digital Diagnostics

Follow : LinkedInYoutube

You May Also Like

More From Author

+ There are no comments

Add yours